Cardiovascular toxicities associated with bispecific T-cell engager therapy
Background Bispecific T-cell engagers (BTEs) are novel agents used to treat hematological malignancies. Early trials were underpowered to define cardiovascular adverse events (CVAE) and no large-scale studies systematically examined the CVAEs associated with BTEs.Methods Leveraging the US Food and D...
Những tác giả chính: | , , , , , , , , , , , , , , , , , |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
BMJ Publishing Group
2024-02-01
|
Loạt: | Journal for ImmunoTherapy of Cancer |
Truy cập trực tuyến: | https://jitc.bmj.com/content/12/2/e008518.full |